Results 21 to 30 of about 3,965 (238)

Systematic review on the cost of seasonal malaria chemoprevention (SMC). [PDF]

open access: yesMalar J
Implemented in 17 countries to date, seasonal malaria chemoprevention (SMC) is a recommended strategy to prevent childhood malaria in areas with seasonal transmission of P. falciparum through monthly administration of antimalarial medicines. Understanding the costs and resource requirements of SMC delivery is necessary for effective planning and ...
Ruisch A   +7 more
europepmc   +4 more sources

Effect of routine seasonal malaria chemoprevention on malaria trends in children under 5 years in Dangassa, Mali [PDF]

open access: goldMalaria Journal, 2020
Abstract Background Seasonal malaria chemoprevention (SMC) is a new strategy to prevent malaria in children under 5 years old. It has been recommended by the World Health Organization since 2012 in malaria-endemic areas with seasonal transmission. This study aimed to assess the changes in malaria indicators through two consecutive years of SMC routine ...
Drissa Konaté   +15 more
openalex   +4 more sources

School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali

open access: yesParasite Epidemiology and Control, 2018
Introduction: Malaria is still a public health problem in Africa. Seasonal Malaria Chemoprevention (SMC) is an efficient control strategy recommended by WHO that targets children under five year old living in areas of seasonal malaria transmission.
Mahamadou A. Thera   +7 more
doaj   +3 more sources

Estimating the potential public health impact of seasonal malaria chemoprevention in African children [PDF]

open access: yesNature Communications, 2012
Seasonal malaria chemoprevention, previously known as intermittent preventive treatment in children, is highly effective in areas with a short malaria transmission season.
Cairns, M.   +7 more
core   +13 more sources

Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria [PDF]

open access: goldBMJ Global Health, 2022
Background In 2012, the WHO issued a policy recommendation for the use of seasonal malaria chemoprevention (SMC) to children 3–59 months in areas of highly seasonal malaria transmission. Clinical trials have found SMC to prevent around 75% of clinical malaria.
Monica Anna de Cola   +12 more
openalex   +7 more sources

Systematic Review and Meta-Analysis of Seasonal Malaria Chemoprevention. [PDF]

open access: yesAm J Trop Med Hyg
ABSTRACT. Seasonal malaria chemoprevention (SMC) for children under 5 years of age for up to four monthly cycles during malaria transmission season was recommended by the WHO in 2012 and has been implemented in 13 countries in the Sahel, reaching more than 30 million children annually.
Thwing J   +3 more
europepmc   +3 more sources

Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique [PDF]

open access: yesMalaria Journal
Background Seasonal malaria chemoprevention (SMC) is a highly effective intervention for malaria prevention in high burden areas with seasonal transmission, historically implemented in the Sahel.
Kevin Baker   +14 more
doaj   +2 more sources

Seasonal malaria chemoprevention in Africa and China's upgraded role as a contributor: a scoping review. [PDF]

open access: goldInfect Dis Poverty, 2023
Xu M   +10 more
europepmc   +3 more sources

Dihydroartemisinin-piperaquine effectiveness for seasonal malaria chemoprevention in settings with extended seasonal malaria transmission in Tanzania

open access: yesScientific Reports
Effectiveness of dihydroartemisinin-piperaquine (DP) as seasonal malaria chemoprevention (SMC) was assessed in Nanyumbu and Masasi Districts. Between March and June 2021, children aged 3–59 months were enrolled in a cluster randomized study.
Richard Mwaiswelo   +7 more
doaj   +3 more sources

Adaptation of lot quality assurance sampling to monitor seasonal malaria chemoprevention delivery performance. [PDF]

open access: yesTrans R Soc Trop Med Hyg
Abstract Malaria Consortium supports delivery of seasonal malaria chemoprevention (SMC) to children ages 3–59 months using sulfadoxine–pyrimethamine plus amodiaquine. Lot quality assurance sampling (LQAS) was adapted as a cost-efficient method for end-of-cycle SMC monitoring surveys across supported countries and an implementation ...
Richardson S   +11 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy